Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Prostatectomy & nephrectomy · Pennsylvania | Prostatectomy & nephrectomy · New York | |
|---|---|---|
| Surgeons, 2024 | 27 | 33 |
| Medicare fee-for-service cases | 1,659 | 2,271 |
| Growth since 2019 (Medicare FFS) | −0.2%/yr | −2.4%/yr |
| Forecast cases (Medicare FFS) | 1,900 in 2030 | 2,710 in 2030 |
| Forecast growth | +2.3%/yr to 2030 | +3%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.3 | 1.4 |
| Medicare Advantage share | 58% | 57% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 61 | 69 |
| Top 10 surgeons' share | 62% | 53% |
| Surgeons growing | 4 | 4 |
| New since the base year | 2 | 2 |
| Likely to stop billing it | 6 by 2026 | 5 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $13K | $14K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.